Immunity Revealed: Stratifying Hepatocellular Carcinoma for Precision Immunotherapy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Liu Y, Ji H, Wu L, Wang X, Yang Y, Zhang Q
. Stratifying hepatocellular carcinoma based on immunophenotypes for immunotherapy response and prognosis. Mol Ther Oncol. 2024; 32(4):200890.
PMC: 11532917.
DOI: 10.1016/j.omton.2024.200890.
View
2.
Arvanitakis K, Mitroulis I, Germanidis G
. Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy. Cancers (Basel). 2021; 13(12).
PMC: 8228651.
DOI: 10.3390/cancers13122899.
View
3.
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag C, Vignat J
. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022; 77(6):1598-1606.
PMC: 9670241.
DOI: 10.1016/j.jhep.2022.08.021.
View
4.
Arvanitakis K, Mitroulis I, Chatzigeorgiou A, Elefsiniotis I, Germanidis G
. The Liver Cancer Immune Microenvironment: Emerging Concepts for Myeloid Cell Profiling with Diagnostic and Therapeutic Implications. Cancers (Basel). 2023; 15(5).
PMC: 10000678.
DOI: 10.3390/cancers15051522.
View
5.
Arvanitakis K, Koletsa T, Mitroulis I, Germanidis G
. Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy. Cancers (Basel). 2022; 14(1).
PMC: 8749970.
DOI: 10.3390/cancers14010226.
View